Regarding applying astrocyte transdifferentiation in Parkinson’s disease, one group used NeuroD1, Ascl1, Lmx1a, and miR-218 to convert astrocytes into dopaminergic neurons in the striatum of PD model mice, and the motor behavior symptoms of the mice were improved [38]. This evidence concerns the gene ASCL1 and Parkinson disease.